Table 1 Acute effects outcomes grouped by domain, presented as mean ± standard deviation, together with statistical significance and effect size (*p < 0.05, **p < 0.01, ***p < 0.001).
From: Acute effects of psilocybin on the dynamics of gaze fixations during visual aesthetic perception
Outcome | Mean ± SD Psilocybin | Mean ± SD Control | p-value | RBC’s r |
|---|---|---|---|---|
Eye-tracking metrics | ||||
N | 77.00 ± 17.19 | 70.80 ± 10.32 | 0.454 | 0.23 |
ds | 146.43 ± 27.42 | 170.19 ± 23.89 | 0.007** | −0.76 |
dt | 0.39 ± 0.08 | 0.41 ± 0.05 | 0.454 | −0.23 |
ds2 | 354.78 ± 41.93 | 381.87 ± 36.33 | 0.035* | −0.62 |
σ(ds) | 129.93 ± 17.68 | 143.22 ± 19.32 | 0.018* | −0.68 |
σ(ds2) | 210.56 ± 17.36 | 220.96 ± 15.35 | 0.035* | −0.62 |
σ(dt) | 0.20 ± 0.03 | 0.20 ± 0.05 | 0.978 | 0.02 |
Shannon entropy (bw = 40) | 5.83 ± 0.14 | 5.90 ± 0.13 | 0.035* | −0.62 |
Shannon entropy (bw = 60) | 5.12 ± 0.15 | 5.19 ± 0.13 | 0.041* | −0.6 |
Shannon entropy (bw = 80) | 4.59 ± 0.15 | 4.67 ± 0.12 | 0.022* | −0.67 |
Shannon entropy (bw = 100) | 4.18 ± 0.15 | 4.25 ± 0.12 | 0.022* | −0.67 |
Intensity effects ratings | ||||
VAS 1 total | 17.56 ± 8.47 | 9.91 ± 3.80 | 0.002 ** | 0.8 |
VAS 2 total | 21.83 ± 7.79 | 11.87 ± 5.19 | 0.0001*** | 0.84 |
VAS 3 total | 20.00 ± 7.56 | 9.35 ± 2.76 | 8e-5 *** | 0.96 |
VAS 4 total | 14.95 ± 8.00 | 7.91 ± 1.35 | 0.001 ** | 0.87 |
Trial-wise ratings | ||||
Emotional valence | 0.52 ± 0.35 | 0.41 ± 0.35 | 0.232 | 0.3 |
Beauty rating | 1.15 ± 0.6 | 1.13 ± 0.51 | 0.708 | 0.1 |
AEQ factors ratings | Cohen’ s d | |||
Emotional | 18.38 ± 5.55 | 15.26 ± 5.79 | 0.004 (**) | 0.55 |
Cultural | 19.48 ± 6.12 | 20.74 ± 6.35 | 0.341 | 0.2 |
Perceptual | 16.14 ± 3.53 | 16.78 ± 4.08 | 0.494 | 0.17 |
Understanding | 17.38 ± 5.36 | 18.04 ± 4.81 | 0.658 | 0.13 |
Flow conditions | 11.19 ± 4.38 | 10.22 ± 2.80 | 0.287 | 0.27 |
Flow experience | 19.81 ± 4.37 | 16.78 ± 4.65 | 0.015 (*) | 0.67 |